Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Perry

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 3. Littoral cell angioma of the spleen in a patient with previous lymphomaJustin D Floyd, Paul A Kaplan, Edward R Sauter, et al.
The Oncologist|October 5, 2007
Small cell lung cancer: have we made any progress over the last 25 years?Brian E Lally, James J Urbanic, A William Blackstock, et al.
Sleep Medicine|November 1, 2003
Prediction of the final MSLT result from the results of the first three napsJoseph A Golish, Bipin D Sarodia, Amy R Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Cardiotoxicity of cancer therapyJustin D Floyd, Duc T Nguyen, Raymond L Lobins, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
Plasma microRNAs as novel biomarkers for early detection of lung cancerDali Zheng, Shadi Haddadin, Yong Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID miceChristopher V Johnson, Tiffani Shelton, Charles J Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancerChandra P Belani, Suresh Ramalingam, Michael C Perry, et al.
Clinical Lung Cancer|February 22, 2007
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734Michael C Perry, Leslie J Kohman, James A Bonner, et al.
The New England Journal of Medicine|December 15, 2006
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerAlan Sandler, Robert Gray, Michael C Perry, et al.
Clinical Breast Cancer|December 9, 2004
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancerVikas Malhotra, Victoria J Dorr, Alan P Lyss, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 3. Littoral cell angioma of the spleen in a patient with previous lymphomaJustin D Floyd, Paul A Kaplan, Edward R Sauter, et al.
The Oncologist|October 5, 2007
Small cell lung cancer: have we made any progress over the last 25 years?Brian E Lally, James J Urbanic, A William Blackstock, et al.
Sleep Medicine|November 1, 2003
Prediction of the final MSLT result from the results of the first three napsJoseph A Golish, Bipin D Sarodia, Amy R Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Cardiotoxicity of cancer therapyJustin D Floyd, Duc T Nguyen, Raymond L Lobins, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
Plasma microRNAs as novel biomarkers for early detection of lung cancerDali Zheng, Shadi Haddadin, Yong Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID miceChristopher V Johnson, Tiffani Shelton, Charles J Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancerChandra P Belani, Suresh Ramalingam, Michael C Perry, et al.
Clinical Lung Cancer|February 22, 2007
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734Michael C Perry, Leslie J Kohman, James A Bonner, et al.
The New England Journal of Medicine|December 15, 2006
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerAlan Sandler, Robert Gray, Michael C Perry, et al.
Clinical Breast Cancer|December 9, 2004
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancerVikas Malhotra, Victoria J Dorr, Alan P Lyss, et al.
Pageof 5